MYRIAD GENETICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.33 USD | +0.63% |
|
-0.27% | +16.41% |
| 03:06pm | Myriad Genetics, GSK Partner to Expand Access to HRD Diagnostic Testing | MT |
| May. 31 | Qiagen, Myriad Genetics Team Up to Develop Homologous Recombination Deficiency Test | MT |
Chart calendar Myriad Genetics, Inc.
f90bb.RPdId3lPpxc76VlP0gYGlzWCDWvcc-VMxOZHfvfHc7k.cLM-EzEX71pNti4su0RBokLxXTGwGoMasJAgNpOKHfN3qHgHICL-b1CkbQ~b2fb8c4bcfbe933a856e1ddd9582b6b0
Upcoming events on Myriad Genetics, Inc.
Past events on Myriad Genetics, Inc.
| 2024-06-06 10:00 am | Annual General Meeting |
| 2024-06-03 02:30 pm | American Society of Clinical Oncology Meeting - Abstract Number:10533 |
| 2024-06-03 02:30 pm | American Society of Clinical Oncology Meeting - Abstract No - 10527 |
| 2024-06-03 10:00 am | American Society of Clinical Oncology Meeting - Abstract Number:5585 |
| 2024-06-03 10:00 am | American Society of Clinical Oncology Meeting - Abstract No - 5617 |
| 2024-06-03 10:00 am | American Society of Clinical Oncology Meeting - Abstract No - 5545 |
| 2024-06-01 04:12 pm | American Society of Clinical Oncology Meeting - Abstract No - 10501 |
| 2024-06-01 10:00 am | American Society of Clinical Oncology Meeting - Abstract No - #3039 |
| 2024-05-30 11:00 am | Leerink Partners Healthcare Crossroads Conference |
| 2024-05-21 11:00 am | Piper Sandler Virtual Cancer Testing Day |
| 2024-05-15 08:15 pm | BofA Securities Health Care Conference |
| 2024-05-07 04:30 pm | Q1 2024 Earnings Call |
| 2024-05-07 04:05 pm | Q1 2024 Earnings Release |
| 2024-04-07 | American Association of Psychiatric Pharmacists Conference |
| 2024-03-05 12:50 pm | TD Cowen Health Care Conference |
| 2024-03-04 04:35 pm | Raymond James Institutional Investors Conference |
| 2024-02-27 04:30 pm | Q4 2023 Earnings Call |
| 2024-02-27 04:05 pm | Q4 2023 Earnings Release |
| 2024-01-10 07:30 pm | JPMorgan Healthcare Conference |
| 2023-11-15 02:00 pm | Stephens Investment Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 851 858 -0.78% | 557 559 -0.28% | 691 687 0.52% | 678 670 1.24% | 753 751 0.27% | 832 |
|
EBITDA Million USD | Released Forecast Spread | 218 209 4.27% | 0,00 0,00 - | 71,9 74,0 -2.9% | -21,0 -20,4 -3.15% | -6,30 -12,8 50.6% | 22,0 |
|
EBIT Million USD | Released Forecast Spread | 145 153 -4.87% | -77,9 -78,1 0.25% | 9,10 5,67 60.51% | -32,8 -34,7 5.51% | -25,5 -29,7 14.13% | 3,91 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 29,0 - | 0,00 0,00 - | -57,1 -41,2 -38.59% | -141 -131 -7.34% | -262 -263 0.17% | -103 |
|
Net income Million USD | Released Forecast Spread | 4,60 24,9 -81.56% | 0,00 0,00 - | -27,2 -100 72.89% | -112 -105 -6.26% | -263 -256 -2.7% | -97,9 |
|
EPS USD | Released Forecast Spread | 0,06 0,33 -81.82% | -3,08 -2,73 -12.82% | -0,35 -0,46 23.91% | -1,39 -1,32 -5.04% | -3,18 -3,13 -1.68% | -0,98 |
| Announcement Date | 13/08/19 | 23/02/21 | 24/02/22 | 28/02/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 165 156 5.64% | 179 170 5.44% | 156 170 -8.2% | 178 169 4.95% | 181 172 5.62% | 184 187 -1.8% | 192 179 7.15% | 197 195 1.01% | 202 193 4.63% | 205 | 207 | 218 | 216 | 221 |
|
EBITDA Million USD | Released Forecast Spread | 10,2 -4,30 337.21% | 7,30 5,40 35.19% | -17,6 0,20 -8900% | -10,7 -10,8 0.93% | -20,5 -18,0 -13.89% | -4,20 -5,25 20% | 1,20 -3,50 134.29% | 10,1 5,25 92.38% | 4,40 -5,55 179.28% | 2,97 | 4,16 | 7,00 | 6,00 | |
|
EBIT Million USD | Released Forecast Spread | -2,80 -8,13 65.55% | 4,50 2,52 78.23% | -20,6 -4,52 -355.31% | -13,9 -15,8 12.11% | -21,9 -20,0 -9.4% | -6,80 -8,68 21.67% | -2,20 -7,64 71.2% | 5,70 1,20 375.56% | -0,60 -12,2 95.08% | -1,30 | 0,50 | 5,31 | 1,37 | 4,46 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -26,4 -30,8 14.29% | -17,9 -21,2 15.57% | -44,2 -30,2 -46.2% | -52,1 -42,5 -22.62% | -52,6 -49,3 -6.71% | -116 -37,0 -213.6% | -61,2 -35,9 -70.6% | -32,3 -30,5 -5.85% | -25,9 -34,2 24.27% | -23,9 | -21,5 | -15,8 | -18,0 | -13,8 |
|
Net income Million USD | Released Forecast Spread | -20,5 -26,2 21.76% | -14,1 -18,1 22.1% | -35,1 -25,4 -38.18% | -42,3 -35,8 -18.09% | -54,7 -38,7 -41.45% | -116 -34,6 -235.17% | -61,3 -31,8 -93.06% | -31,2 -24,5 -27.52% | -26,0 -31,4 17.15% | -24,3 | -21,8 | -16,1 | -18,2 | -14,3 |
|
EPS USD | Released Forecast Spread | -0,26 -0,26 0% | -0,18 -0,16 -16.13% | -0,43 -0,25 -74.32% | -0,52 -0,40 -31.09% | -0,67 -0,42 -60.8% | -1,42 -0,36 -290.83% | -0,75 -0,33 -127.27% | -0,36 -0,29 -23.08% | -0,29 -0,30 4.13% | -0,23 | -0,21 | -0,16 | -0,20 | -0,15 |
| Announcement Date | 05/05/22 | 04/08/22 | 01/11/22 | 28/02/23 | 03/05/23 | 03/08/23 | 06/11/23 | 27/02/24 | 07/05/24 | - | - | - | - | - |
More events
Past sector events for Myriad Genetics, Inc.
| 2024-05-15 | SD BIOSENSOR, INC: Q1 2024 Earnings Release |
| 2024-05-10 09:21 am | DIASORIN S.P.A.: Q1 2024 Earnings Release |
| 2024-05-07 04:05 pm | MYRIAD GENETICS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 04:05 pm | CASTLE BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | LANTHEUS HOLDINGS, INC.: Q1 2024 Earnings Release |
| 2024-04-30 04:05 pm | 10X GENOMICS, INC.: Q1 2024 Earnings Release |
| 2024-04-29 | GETEIN BIOTECH, INC: Q4 2023 Earnings Release |
| 2024-04-29 | GETEIN BIOTECH, INC: Q1 2024 Earnings Release |
| 2024-04-29 | ASSURE TECH (HANGZHOU) CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-29 | SHANDONG ORIENTAL OCEAN SCI-TECH CO., LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MYGN Stock
- Calendar Myriad Genetics, Inc.
